Your browser doesn't support javascript.
loading
The German Aortic Valve Score II.
Schiller, Wolfgang; Barnewold, Linda; Kazmaier, Tonia; Beckmann, Andreas; Masseli, Franz; Welz, Armin; Szecsenyi, Joachim; Heller, Günther.
Afiliación
  • Schiller W; Department of Cardiac Surgery, University of Bonn, Bonn, Germany.
  • Barnewold L; AQUA-Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen GmbH, Göttingen, Germany.
  • Kazmaier T; AQUA-Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen GmbH, Göttingen, Germany.
  • Beckmann A; Department of Cardiac and Vascular Surgery, Heart Center Duisburg, Duisburg, Germany.
  • Masseli F; Department of Cardiac Surgery, University of Bonn, Bonn, Germany.
  • Welz A; Department of Cardiac Surgery, University of Bonn, Bonn, Germany.
  • Szecsenyi J; AQUA-Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen GmbH, Göttingen, Germany.
  • Heller G; IQTIG-Institut für Qualitätssicherung und Transparenz im Gesundheitswesen, Berlin, Germany.
Eur J Cardiothorac Surg ; 52(5): 881-887, 2017 Nov 01.
Article en En | MEDLINE | ID: mdl-28950361
ABSTRACT

OBJECTIVES:

The German Aortic Valve Score (GAVS) was developed for national quality assurance regarding the in-hospital mortality rate of patients following isolated aortic valve replacement. The goal of this work was the recalibration of the GAVS in the context of increased numbers of transcatheter aortic valve implantations.

METHODS:

In 2011 and 2012, 36 183 cases were documented who had either surgical aortic valve replacement or transcatheter aortic valve implantation (45%). All cases were randomly assigned to the study or to the validation group. All items of the data set were checked for significance by developing a multiregression risk model using iterative backward elimination. Calibration was ascertained using the Hosmer-Lemeshow method. To define the quality of discrimination, the area under the receiver operating characteristic curve (C-statistic) was calculated.

RESULTS:

The randomized study cohort comprised 18 054 patients. After modelling with multiple regression algorithms, 18 of the initial 28 risk factors entered the risk model. When applied to the validation group, the newly developed GAVS II showed good calibration with a P-value of 0.411 in the Hosmer-Lemeshow test and good discrimination with a C-statistic of 0.741.

CONCLUSIONS:

The GAVS II is a new risk model that is applicable to cohorts having surgical aortic valve replacement or transcatheter aortic valve implantation procedures.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Válvula Aórtica / Medición de Riesgo / Reemplazo de la Válvula Aórtica Transcatéter Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Eur J Cardiothorac Surg Asunto de la revista: CARDIOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Válvula Aórtica / Medición de Riesgo / Reemplazo de la Válvula Aórtica Transcatéter Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Eur J Cardiothorac Surg Asunto de la revista: CARDIOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Alemania
...